Zacks Research Has Positive View of Lam Research Q1 Earnings

Lam Research Co. (NASDAQ:LRCX - Free Report) - Equities research analysts at Zacks Research upped their Q1 2025 earnings per share (EPS) estimates for Lam Research in a note issued to investors on Thursday, October 17th. Zacks Research analyst R. Department now anticipates that the semiconductor company will post earnings per share of $0.80 for the quarter, up from their previous forecast of $0.80. The consensus estimate for Lam Research's current full-year earnings is $3.52 per share. Zacks Research also issued estimates for Lam Research's Q2 2025 earnings at $0.83 EPS, Q4 2025 earnings at $0.95 EPS, Q3 2026 earnings at $1.07 EPS and Q1 2027 earnings at $1.18 EPS.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The semiconductor company reported $0.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.76 by $0.05. Lam Research had a return on equity of 48.71% and a net margin of 25.68%. The firm had revenue of $3.87 billion for the quarter, compared to analysts' expectations of $3.82 billion. During the same period in the prior year, the business earned $0.60 EPS. The company's revenue for the quarter was up 20.7% compared to the same quarter last year.

A number of other research analysts also recently weighed in on the company. Morgan Stanley dropped their price target on Lam Research from $92.90 to $77.40 and set an "equal weight" rating on the stock in a research note on Tuesday, September 17th. TD Cowen increased their target price on Lam Research from $100.00 to $105.00 and gave the stock a "buy" rating in a report on Thursday, August 1st. Needham & Company LLC restated a "buy" rating and set a $113.00 price target on shares of Lam Research in a research note on Thursday, August 1st. Mizuho lowered their price objective on shares of Lam Research from $105.00 to $95.00 and set an "outperform" rating on the stock in a report on Friday, September 20th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Lam Research from $110.00 to $95.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and an average target price of $141.28.

Lam Research Stock Down 0.4 %

NASDAQ:LRCX traded down $0.30 during trading hours on Friday, reaching $72.84. The company had a trading volume of 18,484,233 shares, compared to its average volume of 11,155,063. The business's 50-day simple moving average is $80.15 and its two-hundred day simple moving average is $90.53. Lam Research has a twelve month low of $57.44 and a twelve month high of $113.00. The firm has a market cap of $9.52 billion, a price-to-earnings ratio of 2.68, a P/E/G ratio of 1.75 and a beta of 1.47. The company has a quick ratio of 2.00, a current ratio of 2.97 and a debt-to-equity ratio of 0.52.

Lam Research Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Tuesday, September 17th were paid a dividend of $0.23 per share. The ex-dividend date of this dividend was Tuesday, September 17th. This represents a $0.92 annualized dividend and a dividend yield of 1.26%. Lam Research's payout ratio is 3.38%.

Insider Activity at Lam Research

In other Lam Research news, CAO Christina Correia sold 647 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the transaction, the chief accounting officer now owns 4,267 shares in the company, valued at $3,488,315.17. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.32% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Lam Research

Large investors have recently made changes to their positions in the stock. Harfst & Associates Inc. raised its stake in shares of Lam Research by 38.7% during the 3rd quarter. Harfst & Associates Inc. now owns 2,289 shares of the semiconductor company's stock valued at $1,868,000 after purchasing an additional 639 shares during the period. Commonwealth Equity Services LLC grew its holdings in Lam Research by 8.4% during the 3rd quarter. Commonwealth Equity Services LLC now owns 42,489 shares of the semiconductor company's stock valued at $34,675,000 after buying an additional 3,283 shares in the last quarter. Capital Investment Advisors LLC increased its position in shares of Lam Research by 27.8% during the third quarter. Capital Investment Advisors LLC now owns 2,390 shares of the semiconductor company's stock valued at $1,951,000 after buying an additional 520 shares during the period. Blue Trust Inc. lifted its holdings in shares of Lam Research by 95.5% in the third quarter. Blue Trust Inc. now owns 2,898 shares of the semiconductor company's stock worth $2,365,000 after buying an additional 1,416 shares in the last quarter. Finally, Generate Investment Management Ltd boosted its position in shares of Lam Research by 62.8% in the third quarter. Generate Investment Management Ltd now owns 20,182 shares of the semiconductor company's stock valued at $16,470,000 after acquiring an additional 7,782 shares during the period. 84.61% of the stock is owned by institutional investors.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.